Toward meeting your research needs, Indivumed is pleased to announce we have complemented our high-quality immunohistochemistry (IHC) services by offering Fluorescent Multiplex IHC with Tyramide Signal Amplification. With this service, up to six targets of interest can be analyzed on one tissue section. Tyramide Signal Amplification ensures the highest sensitivity in fully automated multiplex staining, and whole-slide scans, including seven fluorescent layers, allow complex digital image analyses and long-term storage.
Please join us to explore the benefits of a career with Indivumed.
September 19, 2017
Indivumed and Helomics partner to unlock the power of cancer biospecimens for drug discovery and development
Indivumed GmbH (Indivumed) and Helomics® Corporation (Helomics) announce their intentions to collaborate to analyze human cancer biospecimens and annotated clinical data from consenting patients around the world, enabling cutting-edge basic and translational research in cancer.Read More
August 02, 2017
MedStar Health will collaborate with Indivumed to advance our understanding of the molecular basis of cancer through collection and analysis of biospecimens and clinical data, making possible new individualized diagnosis and treatment of cancer.Read More
April 11, 2017
Hamburg's First Mayor, Olaf Scholz, and international guests from science and business honored Indivumed at its 15-year anniversary.Read More